148 related articles for article (PubMed ID: 21901744)
21. Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome.
Weller M; Nabors LB; Gorlia T; Leske H; Rushing E; Bady P; Hicking C; Perry J; Hong YK; Roth P; Wick W; Goodman SL; Hegi ME; Picard M; Moch H; Straub J; Stupp R
Oncotarget; 2016 Mar; 7(12):15018-32. PubMed ID: 26918452
[TBL] [Abstract][Full Text] [Related]
22. Neuropilin-1 modulates TGFβ signaling to drive glioblastoma growth and recurrence after anti-angiogenic therapy.
Kwiatkowski SC; Guerrero PA; Hirota S; Chen Z; Morales JE; Aghi M; McCarty JH
PLoS One; 2017; 12(9):e0185065. PubMed ID: 28938007
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor-β pathway activity in glioblastoma.
Frei K; Gramatzki D; Tritschler I; Schroeder JJ; Espinoza L; Rushing EJ; Weller M
Oncotarget; 2015 Mar; 6(8):5963-77. PubMed ID: 25849941
[TBL] [Abstract][Full Text] [Related]
24. Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors.
Ikushima H; Todo T; Ino Y; Takahashi M; Miyazawa K; Miyazono K
Cell Stem Cell; 2009 Nov; 5(5):504-14. PubMed ID: 19896441
[TBL] [Abstract][Full Text] [Related]
25. Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomide.
Quann K; Gonzales DM; Mercier I; Wang C; Sotgia F; Pestell RG; Lisanti MP; Jasmin JF
Cell Cycle; 2013 May; 12(10):1510-20. PubMed ID: 23598719
[TBL] [Abstract][Full Text] [Related]
26. Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells.
Tritschler I; Gramatzki D; Capper D; Mittelbronn M; Meyermann R; Saharinen J; Wick W; Keski-Oja J; Weller M
Int J Cancer; 2009 Aug; 125(3):530-40. PubMed ID: 19431147
[TBL] [Abstract][Full Text] [Related]
27. Transforming Growth Factor β Signaling in Colorectal Cancer Cells With Microsatellite Instability Despite Biallelic Mutations in TGFBR2.
de Miranda NF; van Dinther M; van den Akker BE; van Wezel T; ten Dijke P; Morreau H
Gastroenterology; 2015 Jun; 148(7):1427-37.e8. PubMed ID: 25736321
[TBL] [Abstract][Full Text] [Related]
28. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of SMAD2, 4 and 6 mRNA and TGFbeta receptor I mRNA in lesional and non-lesional psoriatic skin.
Yu H; Mrowietz U; Seifert O
Acta Derm Venereol; 2009; 89(4):351-6. PubMed ID: 19688145
[TBL] [Abstract][Full Text] [Related]
30. Modified Panax ginseng Extract Inhibits uPAR-Mediated α[Formula: see text]β1-Integrin Signaling by Modulating Caveolin-1 to Induce Early Apoptosis in Lung Cancer Cells.
Hwang IH; Kwon YK; Cho CK; Lee YW; Sung JS; Joo JC; Lee KB; Yoo HS; Jang IS
Am J Chin Med; 2016; 44(5):1081-97. PubMed ID: 27430913
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia upregulates adhesion ability to peritoneum through a transforming growth factor-beta-dependent mechanism in diffuse-type gastric cancer cells.
Noda S; Yashiro M; Nshii T; Hirakawa K
Eur J Cancer; 2010 Mar; 46(5):995-1005. PubMed ID: 20144860
[TBL] [Abstract][Full Text] [Related]
32. Expression/activation of α5β1 integrin is linked to the β-catenin signaling pathway to drive migration in glioma cells.
Renner G; Noulet F; Mercier MC; Choulier L; Etienne-Selloum N; Gies JP; Lehmann M; Lelong-Rebel I; Martin S; Dontenwill M
Oncotarget; 2016 Sep; 7(38):62194-62207. PubMed ID: 27613837
[TBL] [Abstract][Full Text] [Related]
33. Tumoral RANKL activates astrocytes that promote glioma cell invasion through cytokine signaling.
Kim JK; Jin X; Sohn YW; Jin X; Jeon HY; Kim EJ; Ham SW; Jeon HM; Chang SY; Oh SY; Yin J; Kim SH; Park JB; Nakano I; Kim H
Cancer Lett; 2014 Oct; 353(2):194-200. PubMed ID: 25079688
[TBL] [Abstract][Full Text] [Related]
34. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
35. RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner.
Zhao K; Cui X; Wang Q; Fang C; Tan Y; Wang Y; Yi K; Yang C; You H; Shang R; Wang J; Kang C
Cell Death Dis; 2019 Nov; 10(12):877. PubMed ID: 31754093
[TBL] [Abstract][Full Text] [Related]
36. Microsatellite unstable colorectal cancer cell lines with truncating TGFbetaRII mutations remain sensitive to endogenous TGFbeta.
Baker K; Raut P; Jass JR
J Pathol; 2007 Nov; 213(3):257-65. PubMed ID: 17893910
[TBL] [Abstract][Full Text] [Related]
37. Female mice are more susceptible to developing inflammatory disorders due to impaired transforming growth factor beta signaling in salivary glands.
Nandula SR; Amarnath S; Molinolo A; Bandyopadhyay BC; Hall B; Goldsmith CM; Zheng C; Larsson J; Sreenath T; Chen W; Ambudkar IS; Karlsson S; Baum BJ; Kulkarni AB
Arthritis Rheum; 2007 Jun; 56(6):1798-805. PubMed ID: 17530708
[TBL] [Abstract][Full Text] [Related]
38. Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
Tian F; Byfield SD; Parks WT; Stuelten CH; Nemani D; Zhang YE; Roberts AB
Cancer Res; 2004 Jul; 64(13):4523-30. PubMed ID: 15231662
[TBL] [Abstract][Full Text] [Related]
39. β-elemene inhibits proliferation of human glioblastoma cells through the activation of glia maturation factor β and induces sensitization to cisplatin.
Zhu T; Xu Y; Dong B; Zhang J; Wei Z; Xu Y; Yao Y
Oncol Rep; 2011 Aug; 26(2):405-13. PubMed ID: 21519795
[TBL] [Abstract][Full Text] [Related]
40. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.
Riesco-Eizaguirre G; Rodríguez I; De la Vieja A; Costamagna E; Carrasco N; Nistal M; Santisteban P
Cancer Res; 2009 Nov; 69(21):8317-25. PubMed ID: 19861538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
